Velcora

Velcora is a healthcare and wellness company that operates as a Contract Development and Manufacturing Organization (CDMO) specializing in inhaled and oral drug delivery. Formed by Philip Morris International (PMI) following the acquisitions of Vectura and Fertin Pharma, Velcora integrates expertise in aerosol science and intra-oral delivery technologies. The company provides comprehensive services ranging from formulation development and device design to large-scale manufacturing for pharmaceutical and wellness partners. Its primary focus areas include respiratory health, smoking cessation, and the delivery of active ingredients through innovative formats like gums, pouches, and inhalers. Velcora serves as the cornerstone of PMI's Beyond Nicotine initiative, aiming to leverage medical technology for broader healthcare applications. The organization maintains a global presence with key facilities in the United Kingdom and Denmark.